loader2
Partner With Us NRI

GPT Healthcare Ltd share Price Today

Company details

152.81
157.76
128.70
219.90
6M Return 0.00%
1Y Return -23.10%
Mkt Cap.(Cr) 1,266.44
Volume 165,905
Div Yield 1.62%
OI
-
OI Chg %
-
Volume 165,905

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company GPT Healthcare announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Total Income stood at Rs 101 crore, higher by 3.3% YoY
  • EBITDA stood at Rs 25 crore, with EBITDA margin of 24.6%
  • PAT stood at Rs.13 crore, higher by 23.1% YoY

FY24 Financial Highlights:

  • Total Income stood at Rs 406 crore, higher by 10.6% YoY
  • EBITDA stood at Rs 93 crore, with EBITDA margin of 23.0%, an increase of 16.3% YoY
  • PAT stood at Rs 48 crore, higher by 22.4% YoY
  • The Total Dividend declared for FY24 of Rs 3.5 per share, including final dividend of Rs 1.50 per share

Commenting on the performance, GPT Healthcare Chairman, Dwarika Prasad Tantia, said, “We have always focused on strong operational and financial parameters, along with superior clinical outcomes and this is reflective in our results for the quarter as well as for the year ended March 31, 2024.

The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics with increasing occupancy. The ARPOB for FY24 was Rs 32,947 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance leading to one of the highest Cashflow from Operations to EBITDA for the industry as well as both ROE and ROCE being in excess of 25% each and we expect to maintain the same, giving the shareholders superior return.

With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time. Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas.

Our upcoming hospital in Raipur is on track and is expected to be commissioned in Q4 FY 25 and the radiation oncology to be commissioned in Agartala hospital in CY24.

By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background.”

Result PDF

View Other Company Results

GPT Healthcare Ltd shares SWOT Analysis

Strengths (7)

  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Weakness (2)

  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 157.1
R2 159.9
R3 162.1
Pivot

154.97

S1 152.2
S2 150.0
S3 147.2
EMA SMA
150.4
158.1
-
-
149.3
161.2
-
-
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRT STRATEGIC VENTURES LLP Bulk Purchase 2024-02-29 207.02 891061 NSE
MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED Bulk Purchase 2024-02-29 202.9 705929 NSE
NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Purchase 2024-02-29 208.52 496855 NSE
Name Category Shares
GPT Sons Private Limited PROMOTER 65.57%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

GPT Healthcare Ltd Stocks COMPARISON

Financials( in Cr) GPT Healthcare Ltd Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Global Health Ltd
Price 154.34 927.90 6,207.60 502.25 1,356.20
% Change -0.64 4.25 0.02 3.99 6.17
Mcap Cr 1,266.44 90,183.71 89,255.98 37,917.77 36,414.92
Revenue TTM Cr 361.04 4,831.37 16,612.50 6,537.06 2,694.25
Net Profit TTM Cr 39.01 1,103.51 887.50 632.98 326.08
PE TTM 26.51 85.36 99.43 64.55 76.14
1 Year Return -23.10 60.94 25.38 74.57 116.27
ROCE 23.87 13.85 14.16 7.51 16.49
ROE 24.11 16.12 15.04 6.79 16.13
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 165.36 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 33,119.99 -408.46
LAST 3M 113,155.52 -36,230.77
LAST 6M 183,603.09 -15,050.11
LAST 12M 290,144.87 98,834.05

GPT Healthcare Ltd Information

Stock PE (TTM)
26.51
Promoter Holding
65.57%
Book Value
26.6279
ROCE
23.87%
ROE
24.11%
Description
  • GPT Healthcare Limited was formerly established as "Jibansatya Printing House Private Limited" on August 17, 1989 at Kolkata, West Bengal. The name of Company was changed to "GPT Healthcare Private Limited" by the Registrar of Companies on March 31, 2005. Thereafter, Company converted to a Public Company and the name was changed to "GPT Healthcare Limited". Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021. The Company is one of the leading regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals. It operate a chain of mid-sized hospitals under the "ILS Hospitals" brand and provide integrated healthcare services, focusing on secondary and tertiary care. It operate and manage a network of four multi-specialty hospitals, with a total capacity of 556 beds. It offer a comprehensive range of healthcare services across over 35 specialties and super specialties including internal medicine and diabetology, nephrology, laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology. Each of their hospitals provides integrated diagnostic services and pharmacies catering to patients. Apart from these, it also provide outpatient services, including consultation for a range of ailments and preventive health screenings. Led by the Promoter, Dr. Om Tantia, the first hospital was started in Salt Lake, West Bengal in year 2000, with a capacity of eight beds, which has grown to 85 beds, including 17 beds across various ICUs and HDUs. However, in 2005 the Company purchased a small nursing home consisting of operating theatre, labour room and nursery, diagnostic services, dental clinic and diabetic clinic facilities from Tantia Medical Services Private Limited on a going concern basis for a consideration of Rs 33 million. Later, the Company commissioned a second hospital in Agartala, Tripura in the year 2011 as a multi-specialty tertiary care centre with a capacity of 205 beds with a Nursing School. It established hospital in Dum Dum Kolkata in year, 2013 having a capacity of 150 beds and was authorized to perform renal transplant services. In 2019, it commissioned a tertiary care hospital in Howrah with a capacity of 116 beds and in 2021, has started B.Sc degrees in Nursing training 50 students in every batch from September, 2021. The Company is planning to come out with an initial public offer by raising capital through fresh issue of Rs. 17.5 crore and an offer for sale by issuing 29,887,486 Equity Shares.

Registered Address

GPT Centre JC-25 Sector-III, Salt Lake, Kolkata, West Bengal, 700106

Tel : 91-33-4050 7000
Email : ghl.cosec:gptgroup.co.in
Website : http://www.ilshospitals.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) :
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 544131
NSE Code : GPTHEALTH
Book Closure Date (Month) :
BSE Group : B
ISIN : INE486R01017

FAQ’s on GPT Healthcare Ltd Shares

You can buy GPT Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy GPT Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:56 PM the closing price of GPT Healthcare Ltd was Rs.154.34.

The latest PE ratio of GPT Healthcare Ltd as of Jun 14, 2024 03:56 PM is 26.51

The latest PB ratio of GPT Healthcare Ltd as of Jun 14, 2024 03:56 PM is 0.17

The 52-week high of GPT Healthcare Ltd share price is Rs. 219.90 while the 52-week low is Rs. 128.70

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:56 PM, the market cap of GPT Healthcare Ltd stood at Rs. 1,266.44.

Download App

Download Our App

Play Store App Store
market app